Physician profile
Jane S Noah
NPI 1821068115
$584.70
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $104 · 2021: $23.04.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $147.15 | 2019-2020 | |
| Amgen INC. | $107.11 | 2019-2020 | |
| Therapeuticsmd, INC. | $55.96 | 2019-2020 | |
| Pfizer INC. | $47.60 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $36.09 | 2019-2020 | |
| Coopersurgical, INC. | $29.88 | 2019 | |
| Merck Sharp & Dohme LLC | $29.53 | 2019 | |
| Millicent US INC | $25.81 | 2019 | |
| Medtronic Vascular, INC. | $24.29 | 2019 | |
| Mylan Pharmaceuticals INC. | $23.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.12 | 2019 | |
| Vertical Pharmaceuticals, LLC | $14.02 | 2019 | |
| Novo Nordisk INC | $13.77 | 2019 | |
| Avion Pharmaceuticals | $12.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Noah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.